NO972346L - Aminoguanidinkarboksylater for behandling av ikke-insulinavhengig diabetes millitus - Google Patents

Aminoguanidinkarboksylater for behandling av ikke-insulinavhengig diabetes millitus

Info

Publication number
NO972346L
NO972346L NO972346A NO972346A NO972346L NO 972346 L NO972346 L NO 972346L NO 972346 A NO972346 A NO 972346A NO 972346 A NO972346 A NO 972346A NO 972346 L NO972346 L NO 972346L
Authority
NO
Norway
Prior art keywords
treatment
dependent diabetes
insulin dependent
diabetes millitus
aminoguanidine
Prior art date
Application number
NO972346A
Other languages
English (en)
Other versions
NO308992B1 (no
NO972346D0 (no
Inventor
Scott D Larsen
Valerie A Vaillancourt
Paul D May
Steven P Tanis
John A Tucker
Martin D Meglasson
Heinrich J Schostarez
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/484,547 external-priority patent/US5994577A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO972346D0 publication Critical patent/NO972346D0/no
Publication of NO972346L publication Critical patent/NO972346L/no
Publication of NO308992B1 publication Critical patent/NO308992B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO972346A 1994-11-23 1997-05-22 Aminoguanidinkarboksylater og anvendelse av disse for fremstilling av et medikament for behandling av ikke- insulinavhengig diabetes mellitus NO308992B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34427494A 1994-11-23 1994-11-23
US08/484,547 US5994577A (en) 1994-11-23 1995-06-07 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
PCT/US1995/014126 WO1996016031A1 (en) 1994-11-23 1995-11-13 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus

Publications (3)

Publication Number Publication Date
NO972346D0 NO972346D0 (no) 1997-05-22
NO972346L true NO972346L (no) 1997-07-23
NO308992B1 NO308992B1 (no) 2000-11-27

Family

ID=26993832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972346A NO308992B1 (no) 1994-11-23 1997-05-22 Aminoguanidinkarboksylater og anvendelse av disse for fremstilling av et medikament for behandling av ikke- insulinavhengig diabetes mellitus

Country Status (24)

Country Link
US (2) US6166080A (no)
EP (1) EP0793646B1 (no)
JP (1) JPH10509455A (no)
CN (2) CN1097580C (no)
AT (1) ATE205188T1 (no)
AU (1) AU705893B2 (no)
BR (1) BR9509741A (no)
CA (1) CA2202265A1 (no)
CZ (1) CZ288597B6 (no)
DE (2) DE793646T1 (no)
DK (1) DK0793646T3 (no)
EE (1) EE03392B1 (no)
ES (1) ES2163531T3 (no)
FI (1) FI972185A0 (no)
GE (1) GEP20002026B (no)
HU (1) HUT77133A (no)
MX (1) MX9703807A (no)
NO (1) NO308992B1 (no)
NZ (1) NZ297604A (no)
PL (1) PL184614B1 (no)
PT (1) PT793646E (no)
RU (1) RU2162462C2 (no)
SK (1) SK282357B6 (no)
WO (1) WO1996016031A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526331D0 (en) * 1995-12-22 1996-02-21 Smithkline Beecham Plc Novel method
AU3117497A (en) 1996-05-21 1997-12-09 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
EP0957909A1 (en) * 1997-02-13 1999-11-24 Smithkline Beecham Plc Use of nitric oxid synthase inhibitors for the treatment of diabetes
SE9702457D0 (sv) * 1997-06-26 1997-06-26 Pharmacia & Upjohn Ab Screening
US6001578A (en) * 1997-06-26 1999-12-14 Pharmacia & Upjohn Ab Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential treatments for obesity
US6288124B1 (en) 1998-05-22 2001-09-11 Rima Kaddurah-Daouk Methods of inhibiting undesirable cell growth using an aminoguanidine compound
US6169115B1 (en) 1998-05-22 2001-01-02 Rima Kaddurah-Daouk Use of aminoguanidine analogs for the treatment of diseases of the nervous system
US6815421B1 (en) * 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
WO2009133152A1 (en) * 2008-04-29 2009-11-05 Becton, Dickinson And Company Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition
BRPI0822909B8 (pt) * 2008-06-26 2021-05-25 Laboratorios Silanes S A De C V sal de glicinato de metformina para o controle da glicose sanguínea
GB201300435D0 (en) * 2013-01-10 2013-02-27 Medical Res Council Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases
WO2016171038A1 (ja) * 2015-04-23 2016-10-27 三菱瓦斯化学株式会社 ガス発生剤、及びそれを用いた発泡体の製造方法
US20170056352A1 (en) * 2015-08-25 2017-03-02 Rgenix, Inc. PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
WO2018160178A1 (en) 2017-03-01 2018-09-07 Rgenix, Inc. Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
WO2021119316A1 (en) 2019-12-11 2021-06-17 Rgenix, Inc. Methods of treating cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412105A (en) 1966-01-05 1968-11-19 American Home Prod beta-aryl-n-guanidino-beta-alanines
US3943253A (en) * 1974-06-27 1976-03-09 Barer Sol J Guanido acids as fungicides
JPS54128523A (en) 1978-03-29 1979-10-05 Nippon Carbide Ind Co Ltd 3-guanidinoamino propionic acid and its preparation
US5130324A (en) * 1984-03-19 1992-07-14 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US5272165A (en) * 1984-03-19 1993-12-21 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
IT1201511B (it) 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
US5059712A (en) 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
GB9200114D0 (en) 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase

Also Published As

Publication number Publication date
ATE205188T1 (de) 2001-09-15
US6329545B1 (en) 2001-12-11
CN1377642A (zh) 2002-11-06
NO308992B1 (no) 2000-11-27
SK64097A3 (en) 1997-11-05
BR9509741A (pt) 1997-10-21
ES2163531T3 (es) 2002-02-01
CZ136997A3 (cs) 1998-02-18
RU2162462C2 (ru) 2001-01-27
JPH10509455A (ja) 1998-09-14
MX9703807A (es) 1997-08-30
EP0793646B1 (en) 2001-09-05
PL320361A1 (en) 1997-09-29
SK282357B6 (sk) 2002-01-07
CN1164226A (zh) 1997-11-05
FI972185A (fi) 1997-05-22
PL184614B1 (pl) 2002-11-29
DK0793646T3 (da) 2001-12-17
NO972346D0 (no) 1997-05-22
GEP20002026B (en) 2000-04-10
EP0793646A1 (en) 1997-09-10
EE9700094A (et) 1997-10-15
DE69522580D1 (de) 2001-10-11
CN1097580C (zh) 2003-01-01
FI972185A0 (fi) 1997-05-22
EE03392B1 (et) 2001-04-16
US6166080A (en) 2000-12-26
NZ297604A (en) 2000-07-28
AU4279696A (en) 1996-06-17
HUT77133A (hu) 1998-03-02
AU705893B2 (en) 1999-06-03
CA2202265A1 (en) 1996-05-30
DE793646T1 (de) 1999-12-30
PT793646E (pt) 2002-03-28
CZ288597B6 (cs) 2001-07-11
DE69522580T2 (de) 2002-10-10
WO1996016031A1 (en) 1996-05-30

Similar Documents

Publication Publication Date Title
NO972346L (no) Aminoguanidinkarboksylater for behandling av ikke-insulinavhengig diabetes millitus
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
AU6613896A (en) Chemical compounds
NO307336B1 (no) 2-[(Dihydro)pyrazolyl-3'-oksylmetylen]anilider, anvendelse derav, samt middel inneholdende forbindelsen og mellomprodukter for fremstilling av forbindelsen
MX9700557A (es) Dihidrobenzofuranos.
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
NO20002676D0 (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
EP0330041A3 (de) Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung und ihre Verwendung
NO961356D0 (no) Antracyklinonderivater, samt anvendelse derav ved amyloidose
ATE168105T1 (de) Melamine derivate zur verwendung in der behandlung von krebs
DE69510545D1 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
AU3344697A (en) Pseudopolyrotaxanes
AU648285B2 (en) Coating material, process for producing it and its use
ATE222762T1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
IL158356A0 (en) Benzoheterocycles
DE59108566D1 (de) Heteroarylmethylbenzole-Aromatasehemmer
DE59504397D1 (de) Verwendung von Oberflächennitriertem Molybdän für Strangpressmatrizen
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ES2185154T3 (es) Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia.
TH20047A (th) ซูโดเพพไทด์ที่ถูกเอซิเลทชนิดใหม่ที่มีโทรฟลูออโรเมธิล-ซับสทิทิวเทด 2-อะซาไบไซโคลออคเทน
ATE209493T1 (de) Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression
UY24326A1 (es) Nuevas piperidinas.
UA11675A1 (uk) 1-БЕtА-ОКСИЕТИЛАМІHО-3-КЕТО-5,5-ДИМЕТИЛЦИКЛОГЕКСЕH -1, ЯКИЙ МАЄ АHАЛЬГЕТИЧHУ АКТИВHІСТЬ